Prognostic value of Notch-I expression in hepatocellular carcinoma: A meta-analysis

OncoTargets and Therapy

Volumn 8, Issue , 2015, Pages 3105-3114

  Wu, Tao ^a   Jiao, Min ^a   Jing, Li ^a   Wang, Min Cong ^a   Sun, Hai Feng ^b   Li, Qing ^a   Bai, Yi Yang ^a   Wei, Yong Chang ^a   Nan, Ke Jun ^a   Guo, Hui ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Shaanxi Cancer Hospital   (China)

Author keywords

Clinicopathological features; Hepatocellular carcinoma; Meta analysis; Notch 1; Prognosis

Indexed keywords

NOTCH1 RECEPTOR;

ARTICLE; CANCER STAGING; CLINICAL FEATURE; CONFIDENCE INTERVAL; HAZARD RATIO; HUMAN; LIVER CELL CARCINOMA; METASTASIS; OVERALL SURVIVAL; PORTAL VEIN; PROGNOSIS; PROTEIN EXPRESSION; RISK; SENSITIVITY ANALYSIS; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME;

EID: 84945407571     PISSN: 11786930     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S92945     Document Type: Article

References (31)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-E386.
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.
3. Meyer T. Primary liver cancer. Br J Cancer. 2013;108(4):995-996.
4. DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252-271.
5. Wu G, Wilson G, George J, Qiao L. Modulation of Notch signaling as a therapeutic approach for liver cancer. Curr Gene Ther. 2015;15(2):171-181.
6. Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nature Rev Cancer. 2011;11(5):338-351.
7. South AP, Cho RJ, Aster JC. The double-edged sword of Notch signaling in cancer. Semin Cell Dev Biol. 2012;23(4):458-464.
8. Lobry C, Oh P, Aifantis I. Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think. J Exp Med. 2011;208(10):1931-1935.
9. Hori K, Sen A, Artavanis-Tsakonas S. Notch signaling at a glance. J Cell Sci. 2013;126(Pt 10):2135-2140.
10. Yao K, Rizzo P, Rajan P, et al. Notch-1 and notch-4 receptors as prognostic markers in breast cancer. Int J Surg Pathol. 2011;19(5):607-613.
11. Parr C, Watkins G, Jiang WG. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med. 2004;14(5):779-786.
12. Wang X, Song N, Zhang Y, et al. Coexpression of c-Met and Notch-1 correlates with poor prognosis in resected non-small-cell lung cancer. Tumour Biol. Epub 2015 Apr 14.
13. Donnem T, Andersen S, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer. 2010;116(24):5676-5685.
14. Ogawa R, Ishiguro H, Kimura M, et al. NOTCH1 expression predicts patient prognosis in esophageal squamous cell cancer. Eur Surg Res. 2013;51(3-4):101-107.
15. Xiong Y, Zhang YY, Wu YY, et al. Correlation of over-expressions of miR-21 and Notch-1 in human colorectal cancer with clinical stages. Life Sci. 2014;106(1-2):19-24.
16. Jin HY, Zhang HY, Wang X, Xu J, Ding Y. Expression and clinical significance of Notch signaling genes in colorectal cancer. Tumour Biol. 2012;33(3):817-824.
17. Alniaimi AN, Demorest-Hayes K, Alexander VM, Seo S, Yang D, Rose S. Increased Notch1 expression is associated with poor overall survival in patients with ovarian cancer. Int J Gynecol Cancer. 2015;25(2):208-213.
18. Zhou L, Zhang N, Li QJ, et al. Associations between high levels of Notch1 expression and high invasion and poor overall survival in hepatocellular carcinoma. Tumour Biol. 2013;34(1):543-553.
19. Zhang CD. Detection of Expression and Significance of Notch Signaling in Human Hepatocellular Carcinoma by Using the mRNA Quantitative Analysis [master’s thesis]. Shijiazhuang: Heibei Medical University; 2011.
20. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
21. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.
22. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-605.
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed). 2003;327(7414): 557-560.
24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed). 1997;315(7109):629-634.
25. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-1101.
26. Yu Y, Li X, Zhou L, et al. Clinical significance of expression of microRNA-34a and Notch1 in hepatocellular carcinoma. World Chin J Digestol. 2014;22(14):1943-1952.
27. Zhang Y, Wang DS, Zhou L, et al. Expression and significance of Notch1 in hepatocellular carcinoma. Chin J Dig Surg. 2013;12(5):378-382.
28. Zhang JG, Tian W, Yao C, Shi GS, Chen K, Zhang H. Expressions and significance of Notch1 and ADAM17 in hepatocellular carcinoma. Jiangsu Med J. 2012;38(7):820-823.
29. Pan ZK, Liang YB, Ran WW, Liu ZM, Liang J. Expressions of Notch1 and Notch3 in hepatocellular carcinoma and their clinical significance. Chin Clin Oncol. 2014;19(1):42-45.
30. Ahn S, Hyeon J, Park CK. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2013;12(3):286-294.
31. Hu YJ, Li HY, Qiu KJ, et al. Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK. Int J Mol Med. 2014;34(4):1081-1086.